Browsing Tag
SIL204
2 posts
Next-gen RNA therapy SIL204 passes key safety milestone as Silexion Therapeutics prepares Phase 2/3 pancreatic cancer study
Find out how Silexion Therapeutics is advancing SIL204 after a key safety milestone in pancreatic cancer research.
Silexion Therapeutics’ SIL204 emerges as a potential game-changer in KRAS-driven cancer treatment
Silexion Therapeutics (NASDAQ: SLXN) has taken a major step forward in oncology research, unveiling new preclinical data on…